A randomized double-blind placebo parallel control trial for Chinese herbal bath in the treatment of psoriasis vulgaris (blood heat syndrome)

Phase 1

• Conditions: Psoriasis

• Registration Number: ITMCTR2000003822
• Lead Sponsor: Yueyang Hospital of Integrated Traditional Chinese and Western Medicine

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 20 February 2023

Recruitment & Eligibility

• Status: Pending
• Sex: All
• Target Recruitment: Not specified

Inclusion Criteria

1. Meet the diagnostic criteria of psoriasis vulgaris;
2. Meet the Traditional Chinese Medicine syndromes blood heat syndrome;
3. Aged 18 to 70 years old;
4. Patients who have not been treated for psoriasis in the past one month;
5. Skin lesions <=10% BSA (mild to moderate psoriasis, skin lesions are mainly located in the trunk and/or extremities, palm/soles of the feet, face/scalp, and vulva areas are not included);
6. I agree to receive medical treatment and sign the informed consent.

Exclusion Criteria

1. Women during pregnancy or lactation;
2. Patients with severe organic lesions of visceral organs such as heart, liver, kidney and cerebrovascular, severe primary diseases of hematopoietic system, psychoses and malignant tumors;
3. The skin is affected by infection, trauma, hypersensitive constitution or irritation symptoms.

Study & Design

• Study Type: Interventional study
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Psoriasis Area Severity Index;

Secondary Outcome Measures

Name	Time	Method
Itch self-rating (Visual analogue scale);